Overall, our data suggests that CXCL12 may preferentially activate survival signaling pathways rather than those involved in cell migration in CLL cells, although some of the pathway components (Gi, Erk, Akt) are common nodes. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.